858-449-1310 contact@somatek.com

BLOG

Monoclonal for Alzheimer’s

On Monday FDA approved Biogen’s aducanumab, brand name Aduhelm, through a program called accelerated approval. Aduhelm is the first new medication for Alzheimer’s disease in nearly two decades. FDA’s decision was welcomed by patients and their families as a...

read more

RNA therapeutics

To those developing treatments for oncology, in the gene therapy space and many other fields it seemed for a long time that RNA-based therapies have many attractive properties but somehow just too many obstacles to overcome. Enter recent break-throughs in vaccine...

read more

Molecule(s) of the year

Inspired by Time's Man of the Year the AAAS journal Science used to give out an annual Molecule of the Year award. The award was renamed Breakthrough of the Year in 1996. Last December AAAS announced that for 2020 Breakthrough of the Year was “vaccines against...

read more

San Diego #5 US Biopharma Cluster in 2020

A list of the ten top ranking biopharmaceutical clusters in the US was recently compiled by Genetic Engineering News. The list is based on available 2020 data for NIH funding, venture capital funding, patents, lab space and jobs. San Diego made #5 of the list. Yay!...

read more

Honoring our friend and mentor, Ralph Reisfeld

Our dear friend and mentor, Ralph, passed in December after a long and fruitful life in science. Ralph leaves an important legacy as a pioneer in cancer immunotherapy and as a valued mentor, colleague and friend to many. We will miss him very much and want to share an...

read more

Somatek looks back at 2020

It goes without saying, 2020 was a year with major challenges and disruptions. However, it was also a year of growth and new opportunities for the biotechnology industry and for Somatek. In the summer of 2020, Somatek moved into newly renovated laboratory facilities...

read more

Cold chain is a hot topic among investors

The Pfizer and BioNTech vaccine against COVID-19 received an emergency use authorization from the FDA last Friday, and thousands of doses are being rolled out across the country this week. But the vaccine, which must be stored at between -80 and -60 degrees Celsius, necessitates the utilization of a “cold chain” to keep it within this temperature range from the moment it leaves the manufacturing site to just before it is administered to a patient.

read more